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Early pathologic 
findings and long-term 
improvement in anti- 
Ma2-associated 
encephalitis
Abstract—A 67-year-old m an sequentially developed anti-M a2-associated 
paraneoplastic encephalitis (PNE) and contralateral herpes simplex encephali­
tis  (HSE). B rain biopsy 1 m onth before HSE revealed extensive infiltrates of T 
cells, B cells, and plasm a cells. Most T cells expressed the cytotoxic granu le- 
associated protein TIA-1 and the membranolytic protein granzyme-B. Although 
recovery was thought to be unlikely, treatm ent of the PNE w ith corticosteroids 
and resection of the associated lung cancer resulted in dram atic improvement 
for 21 months.
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Increased clinical awareness and improved tests for 
paraneoplastic neurologic disorders (PNDs) have re­
sulted in early diagnosis and better outcomes for 
some patients. W ith early intervention, syndromes 
once considered monophasic and refractory to tre a t­
m ents m ay indeed improve or have a relapsing- 
rem itting  course.1-2 We report the clinical and 
pathologic findings of a patient who, despite im pres­
sive inflamm atory infiltrates in the brain biopsy, had 
dram atic improvement until the PND recurred 21 
months later.
Case report. A 67-year-old m an p resen ted  in M arch 2000 w ith 
d iplopia noted  w hile p lay ing  golf. H e w as letharg ic  and napping  
m ore th a n  u su a l. A t exam ination , vertical gaze p a resis , horizontal 
saccadic p u rsu it, a tax ia , and  loss of left h an d  d ex te rity  w ere 
noted. In A pril, an M RI revealed  a  no d u lar enhan c in g  lesion in 
th e  r ig h t th a la m u s  and  su p erio r collicular region (figure 1, A 
th rough  C). On April 5, th e  C SF show ed a w h ite  blood cell (WBC) 
count of 18/|aL (89% lym phocytes, 11% monocytes), a  red  blood cell 
(RBC) count of 10/(xL, a  to ta l p ro tein  concentra tion  of 80 mg/dL, 
and glucose of 49 mg/dL; cryptococcal an tigen , acid-fast bacilli, 
VDRL, he rp es sim plex v iru s (HSV), and angio tensin-converting  
enzym e te s ts  w ere negative. C SF hypocretin  levels w ere u n d e tec t­
able. On April 21, s te reo tac tic  biopsy show ed extensive  p e rivascu ­
la r  and  in te rs ti tia l  lym phocytic in filtra te s  w ith num erous p lasm a  
cells (figure 2). Flow cytom etry  and  gene re a rra n g em en t s tud ies 
ru led  out lym phom a. A nti-M a2 an tibodies w ere iden tified  in se­
ru m  (tite r  1:512,000) and C SF (with in tra th ec a l syn thesis; not 
shown), p rom pting  th e  search  for a  tu m o r (figure 3). W hile u n d e r­
going cancer screening, th e  p a tie n t received IV corticosteroids (1 g 
m ethy lpredn iso lone p e r day for 3 days) followed by oral p red ­
nisone th a t  re su lted  in d ram atic  neurologic im provem ent. A chest 
CT scan show ed a sm all sp icu la ted  r ig h t u p p e r lobe lesion associ­
a ted  w ith h ila r  adenopathy; fine needle a sp ira te  of th e  lesion 
dem o n stra ted  an adenocarcinom a.
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On M ay 23, 2000, w hile  on ste ro ids and in p rep ara tio n  for 
su rg e ry , th e  p a tie n t  u n d e rw e n t card iac  c a th e te r iz a tio n  and  
sh o rtly  th e re a f te r  developed se izu res , confusion, an d  a p h as ia  
w ith o u t fever. R epeat M RI show ed n e a r  reso lu tion  of th e  co n trast- 
enhan c in g  abnorm alitie s in th e  r ig h t tem poral and th a lam ic  re ­
gions, and  a  new  a re a  of f lu id -a tte n u a te d  inversion  recovery 
h y p e rin ten s ity  in th e  c o n tra la te ra l m esial tem poral lobe and  in su ­
la r  cortex (figure 1, D th rough  F). R epeat CSF stu d ies  dem on­
s tra te d  an  RBC count of 10/(xL, a  WBC count of 10/(xL (72% 
polym orphonuclear cells, 18% lym phocytes, 10% monocytes), and 
th is  tim e, th e  PC R  for HSV w as positive. T he p a tie n t w as d iag­
nosed w ith he rp es sim plex encephalitis  (HSE) and tre a te d  w ith 
acyclovir. A fter th e  p a tie n t w as neurologically  stab ilized  (although 
im paired  from th e  HSE), a  r ig h t u p p e r and  m iddle lobe pneum o­
nectom y dem o n stra ted  a  1.6-cm focus of m odera te ly  d ifferen tia ted  
in filtra tin g  adenocarcinom a whose cells expressed  th e  M a2 pro­
te in  (d a ta  no t show n). T um or cells w ere also found in 1 of 15 
m ed iastin a l lymph nodes and  th e  p leu ra l fluid (S tage IV lung 
cancer). On Ju n e  29, th e  p a tie n t w as tran s fe rre d  to an  extended 
care  facility  w ith  severe  deficits m ain ly  a ttr ib u te d  to  HSE; h e  w as 
bed bound and followed sim ple com m ands in te rm itten tly .
D u rin g  th e  nex t 3 m onths, th e  p a tie n t’s condition im proved 
significantly , and by A ugust 2000, he  h ad  m ild expressive a p h a ­
sia. By D ecem ber 2000, h e  w as function ing  independently , re a d ­
in g  and  speak ing  norm ally, and  h ad  resu m ed  golfing. H is sh o rt­
te rm  m em ory w as also im proved. H e had  m ild g a it a tax ia , and 
u r in a ry  incontinence only a t n igh t. Serum  t i te r  of anti-M a2 w as 
1:16,000. B ra in  M RI show ed resolu tion  of th e  th a lam ic  no d u lar 
en h an c em e n t, an d  re s id u a l H S E  a b n o rm a litie s  (figure  1, G 
th rough  I). In April 2001, neurologic fbllow-up d em o n stra ted  in ­
te rm itte n t d iplopia and  m ild cognitive deficits; th e  lung cancer 
w as in  “rem ission” desp ite  th e  in itia l G rade IV diagnosis and  th e  
absence of any postsurg ical rad ia tio n  or chem otherapy.
In D ecem ber 2001, 21 m onths a fte r  th e  in itia l p resen ta tio n , 
th e  p a tie n t s ta r te d  rep o rtin g  in te rm itte n t difficulty  w ith down- 
gaze, and  anti-M a2 an tibod ies h ad  increased  to  1:128,000 (see 
figure  3). B ra in  MRI and  a chest rad iog raph  show ed no in te rv al 
change. In J a n u a ry  2002, he  h ad  a se izu re  and w as no longer able 
to rem em ber h is g ran d ch ild ren ’s nam es; exam ination  show ed su ­
p ra n u c lea r dow ngaze p a ralysis, left facial w eakness and hypoes- 
th es ia , m ild left leg w eakness, and im balance. T here  w as m ild 
decreased  tem p e ra tu re  d istal ly in th e  lower ex trem ities; th e  left 
toe response  w as up-going, and th e  r ig h t w as equivocal. The clin­
ical p ic tu re  w as considered a recu rren ce  of h is  PND, and  he  w as 
tre a te d  w ith  oral prednisone, w ith o u t im provem ent. H is s ta tu s  
continued to  decline w ith  deterio ra tion  of cognition and w orsening 
u r in a ry  incontinence. In Ju n e  2002, h e  received pu lsed  IV cortico­
ste ro ids and im m unoglobulins, w ithou t a p p a re n t effect, and  by 
Ju ly , h is g a it w as abnorm ally  slowed, stiffened, and m ore ataxic. 
In A u g u st 2002, th e  se ru m  t i te r  of an ti-M a2 w as 1:256,000. 
P la sm a  exchange w as ineffective, and  by Novem ber, he  re tu rn ed  
to an  ex tended  care  facility. T he p a tie n t died in  M arch 2003 of 
asp ira tio n  pneum onia; no au topsy  w as perform ed.
D iscu ssion . The patien t reported here is rem ark­
able because he had a prolonged neurologic response 
to corticosteroids and tum or resection despite the
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Figure 1. Brain M R I at diagnosis and follow-up. (A through C) M R I at time o f paraneoplastic neurologic disorder diag­
nosis (April 2000). Axial fluid-attenuated inversion recovery (FLAIR) images (A and B) show abnormal hyperintensity in 
the midbrain, right mesial temporal lobe (arrow), and right thalamus. Axial contrast-enhanced T1 magnetic resonance 
(MR) image (C) from the pa tien t’s stereotactic M R I shows abnormal enhancement in the right thalamus, superior collicu- 
lus (arrow), and right mesial temporal lobe. (D through F) M R I at time o f herpes simplex virus encephalitis (May 2000). 
Axial FLAIR images (D and E) show abnormal hyperintensity in the left mesial temporal lobe and insular cortex (arrow) 
consisten t with the diagnosis o f  herpes encephalitis. The focal abnormal signal in tensity in the right mesial temporal lobe 
is related to previous biopsy. Note the near resolution o f abnormal hyperintense signal in the right mesial temporal lobe, 
midbrain, and thalamus. Contrast-enhanced axial T1 M R image (F) shows resolution o f  the previously seen enhancement 
in the right mesial temporal lobe, superior colliculus, and thalamus. (G through I) M R I showing the chronic effects o f  
herpes encephalitis (December 2000). Axial FLAIR M R images (G and H) show extensive abnormal hyperintense signal in 
the left temporal lobe and insular cortex (arrow). There is temporal lobe volume loss with associated compensatory dila ta­
tion o f the left temporal horn o f the lateral ventricle and sylvian fissure. Contrast-enhanced coronal T1 M R image (I) 
shows abnormal T1 shortening related to blood products and subtle enhancement in the left insular cortex and temporal 
lobe (arrows) related to the pa tien t’s previous herpes encephalitis. Note the lack o f significant enhancemen t o f the right 
temporal lobe, midbrain, and thalamus.
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Figure 2. Inflam m atory infiltrates in the mesial temporal lobe a t the time o f paraneoplastic neurologic disorder diagnosis. 
(A through C) Consecutive tissue sections immunolabelecl with CD3, a pan-T-cell marker IA); CD20, a marker o f B  cells 
(B), and CD79, a marker o f plasm a cells (C). Note that the predom inant infiltrates o f T  cells are accompanied by a signif­
icant num ber o f B cells and plasm a cells (XlOO, counterstained with hematoxylin). (D) Hematoxylin and  eosin demon­
strating perivascular cuffing by mononuclear cells (long arrow), and interstitial infiltrates o f mononuclear cells. The short 
arrows point to neurons surrounded by these infiltrates (X200). (E and F) Infiltrates o f T  cells showing expression o f  
TIA-1, a cytotoxic granule-associated protein (E); arrow points to a neuron in close contact with TIA-1 expressing T  cells. 
Most o f these cells use granzyme-B (and less frequently perforin, not shown), membranolytic proteins that induce target 
cell apoptosis (F). For these studies, deparaffined sections were incubated with commercially available antibodies to 
TIA-1 (diluted 1:50; Immunotech, Marseille, France) and granzyme-B (diluted 1:20; Chemicon, Temecula, CA), followed 
by appropriate secondary antibodies, and the reactivity developed with the aviclin-biotin-peroxidase-diaminobenzidine 
method, as reported7 (X400, counterstained with hematoxylin). (G) Deposits o f immunoglobulin (Ig) G in neurons (ar­
rows); this type o f IgG immunolabeling was identified in approximately 10% o f neurons o f a sm all biopsy specimen; no 
IgM  was identified. Glial cells d id  not contain IgG or IgM. For this study, deparaffined sections were reacted with biotin- 
ylatecl goat anti-human IgG or IgM  (diluted 1:2,000) followed by aviclin-biotin-peroxiclase-diaminobenzidine7 (X400, 
counterstained with hematoxylin).
severity of the brain  lymphocytic infiltrates. This im­
provement was associated w ith a decrease of serum  
anti-Ma2 antibody titers th a t persisted until rising 
titers heralded a recurrence of the PND 21 m onths 
later. These findings and the opportunity to examine 
the brain inflamm atory infiltrates a t symptom pre­
sentation m ake th is case notable.
To our knowledge, this is the th ird  patien t with
paraneoplastic3 or cancer-associated limbic encepha­
litis4 occurring in close tem poral association with 
HSE and the first patien t in whom the PND was 
related  to anti-Ma2 antibodies. In our patient, HSE 
developed 2 m onths after the presentation of PND, 
a t which time the PND symptoms and MRI contrast- 
enhancing abnorm alities had improved. It is there­
fore unlikely  th a t  both disorders were directly
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Figure 3. Correlation o f serum cinti-Mci2 antibody titers 
and neurologic symptoms. The graph demonstrates a cor­
relation between serum antibody titers and neurologic 
symptoms. Two CSF samples examined for anti-M a2 an ti­
bodies showed intrathecal synthesis o f  antibodies; the 
small number o f samples precluded the determination o f  
whether the CSF antibody titers correlated with sym p­
toms. H S E  = herpes simplex encephalitis.
cephalitis who died of pulmonary embolism 2 years 
after partial neurologic improvement and symptom 
stabilization; in this patient, no in traneuronal IgG 
was identified (personal observation). These findings 
suggest th a t activated cytotoxic T cells may persist 
in the CNS of patients whose symptoms are stable or 
in apparent remission; they also suggest th a t if an ti­
bodies contribute to the neuronal injury, their role is 
perhaps more critical a t early stages of the disorder 
or a t symptom reactivation.
W hen compared w ith o ther PN Ds,810 pa tien ts  
with anti-M a2 antibodies are more likely to improve 
initially with trea tm ent of the tum or and immuno­
suppressants. It has been suggested th a t the im­
provement is related to the frequent association of 
this syndrome with tum ors of the testis, which are 
amenable to complete resection and are highly re­
sponsive to chemotherapy.5 This patien t and another 
case w ith anti-M a2—associated encephalitis and lung 
cancer (F. Graus, personal communication) indicate 
th a t neurologic improvement may also occur in pa­
tients with tum ors other than  germ-cell neoplasms 
and th a t it is worthwhile to trea t these patients.
related, although the use of corticosteroids probably 
predisposed to the viral infection. We have not found 
this association in 43 other patients w ith anti-Ma2 
encephalitis.5
We were impressed by the extensive num ber of 
inflamm atory infiltrates th a t were m ainly composed 
of T cells bu t also included a significant num ber of B 
cells and p lasm a cells. The presence of brain- 
infiltrating plasm a cells has been reported in other 
patients with anti-M a2 encephalitis6 bu t rarely in 
other types of PND.7 These plasm a cells and in tran ­
euronal deposits of immunoglobulin (Ig) G suggest 
th a t antibodies m ight have contributed to the neuro­
nal injury, but the lim ited am ount of tissue and the 
fact th a t it  was embedded in paraffin did not allow 
further characterization of the in traneuronal IgG. 
The m ain effectors of neuronal injury seemed to be 
the cytotoxic T cells th a t  abundan tly  expressed 
TIA-1 (a cytotoxic granule-associated protein), and 
used granzyme B and less frequently perforin (data 
not shown), two membranolytic proteins th a t induce 
target cell apoptosis. We found a sim ilar usage of 
granzyme-B by scattered brain TIA-1 expressing T 
cells in the autopsy of a patien t w ith anti-M a2 en-
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